MentionFoxImmunophotonics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-04.
Immunophotonics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 4, 2026. The filing reports $10.15M sold. Its industry group is Pharmaceuticals. It names Alexander Hurst (Executive Officer), Robert Arch (Executive Officer), Miguel Zubizarreta (Director) (SEC Form D, September 4, 2026).
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Immunophotonics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Immunophotonics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Immunophotonics, Inc. →Get the full cited report on Immunophotonics, Inc.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immunophotonics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Immunophotonics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $10.15M, on the same scale — one filing against the whole group's total, so it sits low by construction.
A portion of the gross proceeds will be used for general working capital, a portion of which will include normal salary payments to executive officers. An estimate of such amount is unknown at this time.
By form type: D ×6.
| Form | Filed | On EDGAR |
|---|---|---|
| D | 2026-09-04 | open |
| D | 2024-03-15 | open |
| D | 2023-02-14 | open |
| D | 2015-01-21 | open |
| D | 2011-06-28 | open |
| D | 2010-05-12 | open |
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immunophotonics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Immunophotonics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The 6 most recent of 6 filings on CIK 0001490953, filed as Immunophotonics, Inc.. Read from the SEC's own submissions feed for this issuer, not from a third party. Incorporated in DE. Full history on sec.gov.
Checked away from the filing. What is below does not come from the record on sec.gov.
Immunophotonics' proprietary glycan polymer enhances antigen capture & immune processes, unlocking platform potential for immunotherapy.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Alexander Hurst is named as Executive Officer on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Robert Arch is named as Executive Officer on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Miguel Zubizarreta is named as Director on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Luciano Alleruzzo is named as Director and Promoter on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Jonathan Knowles is named as Director on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Wei Chen is named as Director and Promoter on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records searched under this name on 10 September 2026 returned items warranting review. A shared name is a possible match and not a finding, and this page does not say what came back or where. Order the full report on Wei Chen to settle which records belong to this person and which do not.
Jacqueline Hess is named as Director on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Richard Levenson is named as Director on the Form D that Immunophotonics, Inc. filed with the SEC on 4 September 2026, one of 8 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2026-09-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Immunophotonics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Immunophotonics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-25 (immunophotonics.com).
Each opens in a new tab, filled in for Immunophotonics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/immunophotonics-inc-form-d-000003